Menu
Oslo, Norway, 24 January 2025: Jorunn Sandnes, a close associate of chairperson of the board of Thor Medical ASA, Ludvik Sandnes, has been allocated 50,000 shares in the subsequent offering of Thor Medical ASA at the subscription price of NOK 2.5 per share.
Primary insider notifications pursuant to the market abuse regulation article 19 are attached.
This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 19 and the Norwegian Securities Trading Act section 5-12.
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visit www.thormedical.no - https://www.thormedical.no.
